Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marwan Fakih
Institutions:
City Of Hope National Medical Center,
City of Hope
Observed institutions:
City Of Hope National Medical Center,
City of Hope
ORCID:
0000-0002-6554-5488
Observed ORCID:
0000-0002-6554-5488
OpenAlex ID:
A5135861369
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D
2024
·
Richard Kim
, Mustapha Tehfe
, et al.
·
Clinical Colorectal Cancer
·
22
Impact of medical and surgical intervention on survival in patients with cholangiocarcinoma
2013
·
Amanda K Arrington
, Rebecca A Nelson
, et al.
·
World Journal of Gastrointestinal Surgery
·
11
PDF
Positron emission tomography as predictor of rectal cancer response during or following neoadjuvant chemoradiation
2010
·
Shane Hopkins
, Marwan Fakih
, et al.
·
World Journal of Gastrointestinal Oncology
·
9
PDF
SWOG S2107: Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated MSS, BRAF V600E metastatic colorectal cancer (mCRC).
2026
·
Van K. Morris
, Sarah Colby
, et al.
·
Journal of Clinical Oncology
·
6
PDF
Initial phase 1 study results of NT-175 engineered T-cell therapy in TP53 R175H–mutated unresectable advanced solid tumors.
2026
·
Rishi Surana
, Adam Jacob Schoenfeld
, et al.
·
Journal of Clinical Oncology
·
5
Combined Liver and Colon Resection of Synchronous Colorectal Liver Metastases at a Quaternary Center
2023
·
Kevin Choong
, Paul Wong
, et al.
·
Journal of Surgical Research
·
3
Impact of Systematic Discontinuation of Mitomycin C HIPEC for Colorectal Peritoneal Metastases on Oncologic Outcomes: A Propensity Score-Matched Analysis
2026
·
M. Daniyal Tanweer
, Muhammad Talha Waheed
, et al.
·
Annals of Surgical Oncology
·
1
PDF
A phase 1, first-in-human (FIH), dose-escalation and dose-optimization study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 T-cell engager in participants with advanced or metastatic microsatellite-stable (MSS)/microsatellite instability–low (MSI-L) colorectal cancer (CRC).
2026
·
Alexander I. Spira
, David Sommerhalder
, et al.
·
Journal of Clinical Oncology
·
1
PDF
A randomized, active-controlled phase 3 study of ivonescimab + FOLFOX versus bevacizumab + FOLFOX as first-line treatment of metastatic colorectal cancer (mCRC): HARMONi-GI3.
2026
·
Aparna Raj Parikh
, Michael J. Overman
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Locoregional Control from Complete Peritoneal Cytoreduction in Patients with Extraperitoneal Colorectal Cancer Metastases: An Entropy Balanced Analysis
2026
·
M. Daniyal Tanweer
, Isaac B. Paz
, et al.
·
Annals of Surgical Oncology
·
1
Impact of concurrent tissue (TBx) and liquid (LBx)–based comprehensive genomic profiling (CGP) on biomarker detection and first-line (1L) treatment in metastatic CRC (mCRC).
2026
·
Jessica Lee
, Amaya Gasco Hernandez
, et al.
·
Journal of Clinical Oncology
Phase 1 study of the tetravalent death receptor 5 agonist ozekibart (INBRX-109) combined with chemotherapy in locally advanced or metastatic, unresectable colorectal adenocarcinoma (CRC).
2026
·
Hazel Lote
, Olatunji B. Alese
, et al.
·
Journal of Clinical Oncology
ASO Visual Abstract: Locoregional Control from Complete Peritoneal Cytoreduction in Patients with Extraperitoneal Colorectal Cancer Metastases: An Entropy Balanced Analysis
2026
·
M. Daniyal Tanweer
, Isaac B. Paz
, et al.
·
Annals of Surgical Oncology
EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Factor Receptor–Based Therapy in Metastatic Colorectal Cancer
2026
·
Toshiaki Takahashi
, Alessandro Mannucci
, et al.
·
JCO Precision Oncology
Show more works
View as search
Works count:
14
Citation count:
60
H-index:
5
I10-index:
2
Year
Topic
Type